HC Wainwright & Co. Reiterates Buy on PolyPid, Maintains $13 Price Target

Benzinga · 2d ago
HC Wainwright & Co. analyst Brandon Folkes reiterates PolyPid (NASDAQ:PYPD) with a Buy and maintains $13 price target.